000 | 01588 a2200457 4500 | ||
---|---|---|---|
005 | 20250513112555.0 | ||
264 | 0 | _c19970304 | |
008 | 199703s 0 0 eng d | ||
022 | _a0093-7754 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Warmerdam, L J | |
245 | 0 | 0 |
_aClinical pharmacology of carboplatin administered in combination with paclitaxel. _h[electronic resource] |
260 |
_bSeminars in oncology _cFeb 1997 |
||
300 |
_aS2-97-S2-104 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
700 | 1 | _aHuizing, M T | |
700 | 1 | _aGiaccone, G | |
700 | 1 | _aPostmus, P E | |
700 | 1 | _aten Bokkel Huinink, W W | |
700 | 1 | _avan Zandwijk, N | |
700 | 1 | _aKoolen, M G | |
700 | 1 | _aHelmerhorst, T J | |
700 | 1 | _avan der Vijgh, W J | |
700 | 1 | _aVeenhof, C H | |
700 | 1 | _aBeijnen, J H | |
773 | 0 |
_tSeminars in oncology _gvol. 24 _gno. 1 Suppl 2 _gp. S2-97-S2-104 |
|
999 |
_c9033845 _d9033845 |